Analyzing the import of Vitamin B1 to China from 2013 to 2023, it is evident that the market has seen significant fluctuations. In 2013, the value stood at 1.707 million USD and experienced a dramatic increase in 2014, followed by a substantial drop in 2015. Up until 2017, the market showed signs of recovery and stability. From 2018 onwards, consistent growth was observed, culminating in a value of 3.6874 million USD in 2023. Year-on-year variations demonstrate the volatility, with fluctuations ranging between negative and positive changes. Over the last five years (2018-2023), the compound annual growth rate (CAGR) averaged at around 3.9%.
Future projections (2024-2028) forecast a steady increase in the value of imports, reaching 4.3166 million USD by 2028. The forecasted five-year CAGR is expected to be approximately 2.38%, with a total growth rate of 12.46% over this period. Trends suggest a cautious but consistent upward trajectory.
Future trends to watch for include potential impacts of global supply chain disruptions, changes in international trade policies, and emerging alternatives in the health supplement market. Additionally, technological advancements in vitamin synthesis and rising health consciousness in China could further influence import dynamics.
